Mi Propio Camino Intervention RCT for Blood Pressure Medication Adherence
MPC
Mi Propio Camino (Finding My Own Way): Personalized Approaches to Improve Blood Pressure Control
2 other identifiers
interventional
511
1 country
1
Brief Summary
The purpose of this study is to compare the effect of two educational interventions on adherence to blood pressure medications among adults with uncontrolled hypertension.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable hypertension
Started Sep 2020
Longer than P75 for not_applicable hypertension
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 16, 2020
CompletedFirst Submitted
Initial submission to the registry
October 6, 2020
CompletedFirst Posted
Study publicly available on registry
October 14, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 10, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 10, 2024
CompletedResults Posted
Study results publicly available
February 24, 2026
CompletedFebruary 24, 2026
February 1, 2026
4 years
October 6, 2020
January 17, 2026
February 4, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Medication Adherence (Objective)
Medication adherence is assessed at 6-month follow-up with Medication Event Monitoring System (MEMS) pill bottle cap monitors (MWV/WestRock), an objective, gold-standard measure for pill-taking behavior. MEMS caps can be affixed to a medicine bottle to record each time the bottle is opened, indicating when the patient took the medication. Daily adherence is defined as the proportion of days that the prescribed number of doses was taken by the patient during a 30-day period.
6 months post-intervention
Secondary Outcomes (5)
Medication Adherence (Subjective)
6 months post-intervention
Number of Participants Who Were Nonadherent Due To Beliefs (Subjective)
6 months post-intervention
Medication-related Beliefs (Specific)
5 months post-intervention
Systolic Blood Pressure
6 months post-intervention
Diastolic Blood Pressure
6 months post-intervention
Other Outcomes (3)
Medication-related Information
Collected for analysis at baseline, upon completion of intervention period and upon completion of outcome assessment period at 1-month and 6-month follow up.
Medication-related Behavioral Skills
Collected for analysis at baseline, upon completion of intervention period and upon completion of outcome assessment period at 1-month and 6-month follow up.
Activation of Behavioral Strategies
Collected for analysis at baseline, upon completion of intervention period and upon completion of outcome assessment period at 1-month and 6-month follow up.
Study Arms (2)
Mi Propio Camino (MPC; My Own Way)
EXPERIMENTALParticipants will complete the MPC intervention alongside usual care for hypertension
Habilidades para Controlar la Presion (HCP; Skills for Blood Pressure Control)
ACTIVE COMPARATORParticipants will complete the HCP intervention alongside usual care for hypertension.
Interventions
The Mi Propio Camino (MPC) intervention will be comprised of four sessions. Session 1 will encompass: the facts about high blood pressure (BP), understanding blood pressure readings, provide an overview of changes one can make to manage their BP, introduce MPC personal experience monitoring, and usage the mHealth kit. Subsequently, sessions 2-4 will emphasize the benefits of personal experience monitoring through 1) personal insight (finding what works for them) and 2) empowerment to work with their providers. Session 2 will reinforce this by introducing: synergy between medication and lifestyle, principles of heart-healthy eating and physical activity. Session 3 will incorporate discussion of negative beliefs about medication and patient directed lifestyle learning-rotating stations. Lastly, session 4 will introduce the continuation of personal experience monitoring on their own through the use of behavioral strategies for adherence and provider communication strategies.
The HCP intervention will be comprised of four sessions and introduce seven lifestyle strategies (LS) subdivided per these sessions. Session 1 will encompass the facts about high blood pressure (BP), understanding blood pressure readings, provide an overview of changes one can make to manage their BP, present specific health threats from high BP, and incorporate LS1: taking control of your medication. Subsequently, sessions 2-4 will reinforce the benefits of taking medications through presenting 1) reduced risk for complications and 2) strategies to remember to take medications. Session 2 will present LS2: eating a well-balanced, low-salt diet and LS3: enjoying regular physical activity. Session 3 will follow with introducing LS4: maintaining a healthy weight and LS5: shaking the salt habit while eating out. Session 4 will present LS6: managing stress and LS7: working together with their doctor followed by a review of strategies they can continue on their own.
Eligibility Criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Health Policy Research Institute
Irvine, California, 92697, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
Objective adherence was measured using MEMS caps, which record bottle-opening events and may not perfectly correspond to ingestion; this limitation is inherent to all electronic monitoring approaches.
Results Point of Contact
- Title
- John Billimek
- Organization
- University of California, Irvine
Study Officials
- PRINCIPAL INVESTIGATOR
John Billimek, PhD
University of California, Irvine
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Faculty
Study Record Dates
First Submitted
October 6, 2020
First Posted
October 14, 2020
Study Start
September 16, 2020
Primary Completion
September 10, 2024
Study Completion
September 10, 2024
Last Updated
February 24, 2026
Results First Posted
February 24, 2026
Record last verified: 2026-02